Stephen Mitchener, SVP, Chief Business Officer at Karyopharm Therapeutics Inc. (KPTI), sold 6,357 shares at $3.03 ($19K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $19k KPTI by SVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |